Palisade Bio, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Palisade Bio, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Shareholder Slice Ratio: Share count rose 40,185% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than 97% of Healthcare companies in United States.
- Debt Due Cover Ratio: Operating cash was negative last year, while some debt falls due within a year. Lower than 88% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
1/3 · 1/3Sales grew in 1 of the last 3 years; profit grew in 1 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-152.8×Operating cash was negative last year, while some debt falls due within a year.
Lower than 88% of Healthcare companies in United States.
Cash Cushion Ratio
+57%Cash, after subtracting all debt, equals 57% of its market value (net cash).
Higher than 79% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
Palisade Bio, Inc. owes $0.04 for every $1 it owns. Palisade Bio, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
2.2Investors pay $2.2 for every $1 of Palisade Bio, Inc.'s yearly profit, lower than 90% of Healthcare companies in United States.
P/B ratio
1.93The share price is 1.93 times Palisade Bio, Inc.'s book value per share, lower than 60% of Healthcare companies in United States.
Market cap
$235 MThe total market value of all of Palisade Bio, Inc.'s shares at today's price (share price × number of shares), smaller than 56% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$122 MWhat Palisade Bio, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.70Net worth divided by the number of shares. The share price of $1.35 is 1.9 times this, which is the P/B above.
Return on equity (ROE)
-51.4%Palisade Bio, Inc. lost 51.4% of its shareholders' money over the last year, lower than 52% of Healthcare companies in United States.
Owes vs Owns
0.04×Palisade Bio, Inc. owes $0.04 for every $1 it owns (low), lower than 97% of Healthcare companies in United States.
Dividend yield
NonePalisade Bio, Inc. does not currently pay a dividend.
Profit growth
LossPalisade Bio, Inc. made a loss in each of the last two years.
Interest cover
Not coveredPalisade Bio, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashPalisade Bio, Inc. held $133 M more cash than debt (net cash) at Dec 2025.
Questions
What is Palisade Bio, Inc.'s P/E ratio?
Investors pay $2.2 for every $1 of Palisade Bio, Inc.'s yearly profit, lower than 90% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Palisade Bio, Inc.: $235 M ÷ $122 M (30 Jun 2026) = 1.9.
What is Palisade Bio, Inc.'s return on equity?
Palisade Bio, Inc. lost 51.4% of its shareholders' money over the last year, lower than 52% of Healthcare companies in United States.
How much does Palisade Bio, Inc. owe compared with what it owns?
Palisade Bio, Inc. owes $0.04 for every $1 it owns (low), lower than 97% of Healthcare companies in United States.
Does Palisade Bio, Inc. pay a dividend?
No. Palisade Bio, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.